Data / Form D filings / Psy Therapeutics, Inc.
Psy Therapeutics, Inc.: Form D filings
Psy Therapeutics, Inc., a pharmaceuticals company in Boston, MA, filed 5 Form D notices with the SEC between 2019 and 2025. The latest, on September 12, 2025, reports $6.8 million sold of a $20.4 million offering to 23 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 28 ATLANTIC AVE, SUITE 222, Boston, MA, 02110
- Phone
- (617) 723-5429
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1788222
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | Amendment | $20,400,000 | $6,762,848 | $13,637,152 | 23 | Dec 23, 2021 | sec.gov |
| Aug 9, 2024 | Amendment | $20,400,000 | $5,847,848 | $14,552,152 | 16 | Dec 23, 2021 | sec.gov |
| Aug 10, 2023 | Amendment | $20,400,000 | $3,972,115 | $16,427,885 | 10 | Dec 23, 2021 | sec.gov |
| Dec 28, 2021 | New notice | $20,400,000 | $2,772,615 | $17,627,385 | 6 | Dec 23, 2021 | sec.gov |
| Oct 2, 2019 | New notice | $4,297,692 | $3,967,692 | $330,000 | 19 | Sep 23, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David S. Barlow | Executive Officer, Director | |
| Paul F. Murphy | Director | |
| Alan S. Cross | Director | |
| William F. Wagner | Executive Officer | |
| Jerry F. Rosenbaum | Director | |
| Daniel S. Weiss Pick | Director | |
| Jeff S. Troderman | Executive Officer |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Sep 8, 2025 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Psy Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.